Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities (Details)

v3.20.1
Accrued Expenses And Other Current Liabilities (Details) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]    
Research and development expenses $ 1,873,361 $ 920,901
Compensation and benefits 1,413,014 1,591,964
General and administrative 1,035,454 120,056
Sales and marketing 207,950 360,016
Sales returns and allowances 1,361,410 2,284,175
Medicaid rebates 95,410 118,271
Other 207,606 244,869
Total accrued expenses and other current liabilities 6,194,205 $ 5,640,252
Executive Officer    
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]    
Accrued compensation $ 300,000